In addition, drugs targeting NMTs (NMT1 and NMT2) have been suggested to be potent senolytics (McHugh et al., 2023) and a target for treating or preventing various diseases such as cancer (Thinon et al., 2016; Zhu et al., 2021) and heart failure (Tomita et al., 2023). The gene discussed is NMT1; the disease is heart failure.